Kantar, LLC
Companies that offer so-called transgender healthcare for their employees and covered dependents.
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
MediumRationale:
Kantar received a score of 70 on the 2025 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. The company recruits employees based on sexual identity issues. The company discriminates against vendors that do not promote divisive sex and gender policies, indicating it prioritizes sexual issues over merit (1)(2). However, the company has not canceled customers, suppliers, or vendors based on political views or religious beliefs (3).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
HighCriteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighCorporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
HighRationale:
Kantar supports DEI within its business practices, employing a Global Head of Diversity, Equity & Inclusion (1)(2). The company offers a “Global Allyship Programme” (3). Kantar scored an 80 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group (4)(5).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
MediumRationale:
Kantar’s HRC 2025 CEI rating indicates the company covers transgender related costs for its employees and their children, including paid short-term leave, puberty blockers, cross-sex hormones, chest surgeries, genital surgeries, medical visits and lab monitoring, travel and lodging (1)(2). Otherwise, there are no publicly known cases of the company using corporate funds to advance ideological causes, organizations, or policies (3).